Fritz C. Eilber
- Biotechnology top 0.2%
- Cancer Research and Treatments 36
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment 77
- Rheumatology top 0.5%
- Bone Tumor Diagnosis and Treatments 17
- Oncology top 1%
- Vascular Tumors and Angiosarcomas 20
- CAR-T cell therapy research 13
-
- Cardiac tumors and thrombi 12
-
- Nanoplatforms for cancer theranostics 29
-
- Virus-based gene therapy research 26
- Co-authors
- Sarah DryFrederick R. EilberScott D. NelsonWilliam D. TapJ J EckardtArun S. SinghGerald RosenJohannes Czernin
- Partner nations
- United StatesJapanGermany
In The Last Decade
Fritz C. Eilber
115 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 109
- Biotechnology 980
- Pulmonary and Respiratory Medicine 3.0k
- Rheumatology 1.0k
- Oncology 1.8k
- Cardiology and Cardiovascular Medicine 965
Countries citing papers authored by Fritz C. Eilber
This map shows the geographic impact of Fritz C. Eilber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fritz C. Eilber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fritz C. Eilber more than expected).
Fields of papers citing papers by Fritz C. Eilber
This network shows the impact of papers produced by Fritz C. Eilber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fritz C. Eilber. The network helps show where Fritz C. Eilber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fritz C. Eilber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 16 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 77 | |
| 7 | 2020 | 43 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 15 | |
| 10 | 2018 | 17 | |
| 11 | 2018 | 17 | |
| 12 | 2017 | 3 | |
| 13 | 2014 | 46 | |
| 14 | 2013 | 27 | |
| 15 | 2013 | 22 | |
| 16 | 2012 | 27 | |
| 17 | 2012 | 131 | |
| 18 | 2011 | 8 | |
| 19 | 2007 | 5 | |
| 20 | 2006 | 13 |
About Fritz C. Eilber
Fritz C. Eilber is a scholar working on Biotechnology, Pulmonary and Respiratory Medicine and Oncology, having authored 121 papers that have together received 5.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (77 papers), Cancer Research and Treatments (36 papers), Nanoplatforms for cancer theranostics (29 papers), Virus-based gene therapy research (26 papers), Vascular Tumors and Angiosarcomas (20 papers), Bone Tumor Diagnosis and Treatments (17 papers), CAR-T cell therapy research (13 papers) and Cardiac tumors and thrombi (12 papers). The work is most often cited by research in Biotechnology (980 citations), Pulmonary and Respiratory Medicine (3.0k citations) and Rheumatology (1.0k citations). Fritz C. Eilber has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Sarah Dry, Frederick R. Eilber, Scott D. Nelson, William D. Tap, J J Eckardt, Arun S. Singh, Gerald Rosen, Johannes Czernin, Noah Federman and Nicholas M. Bernthal. Their work appears in journals such as Oncotarget, Cell Cycle, Journal of Cellular Biochemistry, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.